HER2 Support Group Forums - View Single Post - Clinical Trial for PTEN-deficient Mets progressing on trastuzumab-based therapy

AlaskaAngel · 05-24-2006, 08:55 AM

Phase I-II Study of Trastuzumab in Combination With RAD001 in Patients With HER-2 Overexpressing, PTEN-Deficient Metastatic Breast Cancer Progressing on Trastuzumab-Based Therapy
This study is currently recruiting patients.
Verified by M.D. Anderson Cancer Center May 2006

http://www.clinicaltrials.gov/ct/gui...17720?order=13

05-24-2006, 08:55 AM	#1
AlaskaAngel Senior Member Join Date: Sep 2005 Location: Alaska Posts: 2,018	Clinical Trial for PTEN-deficient Mets progressing on trastuzumab-based therapy Phase I-II Study of Trastuzumab in Combination With RAD001 in Patients With HER-2 Overexpressing, PTEN-Deficient Metastatic Breast Cancer Progressing on Trastuzumab-Based Therapy This study is currently recruiting patients. Verified by M.D. Anderson Cancer Center May 2006 http://www.clinicaltrials.gov/ct/gui...17720?order=13 Last edited by AlaskaAngel; 05-24-2006 at 08:57 AM.. Reason: More correct title